Authors:
Guiban, D
Massias, JF
Dugue, MA
Coste, J
Bertagna, X
Raffin-Sanson, ML
Citation: D. Guiban et al., A new generation IRMA for ACTH with improved specificity: validation in various physiological and pathological conditions, EUR J ENDOC, 144(4), 2001, pp. 369-377
Authors:
Boulle, N
Baudin, E
Gicquel, C
Logie, A
Bertherat, J
Penfornis, A
Bertagna, X
Luton, JP
Schlumberger, M
Le Bouc, Y
Citation: N. Boulle et al., Evaluation of plasma insulin-like growth factor binding protein-2 as a marker for adrenocortical tumors, EUR J ENDOC, 144(1), 2001, pp. 29-36
Authors:
Gicquel, C
Bertagna, X
Gaston, V
Coste, J
Louvel, A
Baudin, E
Bertherat, J
Chapuis, Y
Duclos, JM
Schlumberger, M
Plouin, PF
Luton, JP
Le Bouc, Y
Citation: C. Gicquel et al., Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors, CANCER RES, 61(18), 2001, pp. 6762-6767
Authors:
Raffin-Sanson, ML
de Keyzer, Y
Bertagna, X
Citation: Ml. Raffin-sanson et al., Syndromes of ectopic ACTH secretion: Recent pathophysiological progresses and their clinical implications, ENDOCRINOLO, 10(2), 2000, pp. 97-106
Authors:
Gicquel, C
Bertherat, J
Le Bouc, Y
Bertagna, X
Citation: C. Gicquel et al., Pathogenesis of adrenocortical incidentalomas and genetic syndromes associated with adrenocortical neoplasms, END METAB C, 29(1), 2000, pp. 1
Authors:
Raffin-Sanson, ML
Ferre, F
Coste, J
Oliver, C
Cabrol, D
Bertagna, X
Citation: Ml. Raffin-sanson et al., Pro-opiomelanocortin in human pregnancy: evolution of maternal plasma levels, concentrations in cord blood, amniotic fluid and at the feto-maternal interface, EUR J ENDOC, 142(1), 2000, pp. 53-59
Citation: Jp. Luton et al., Familial diseases of the adrenal gland: progress in molecular medicine andrisks of genetic screening, PRESSE MED, 29(16), 2000, pp. 900-903
Authors:
Rene, P
Lenne, F
Ventura, MA
Bertagna, X
de Keyzer, Y
Citation: P. Rene et al., Nucleotide sequence and structural organization of the human vasopressin pituitary receptor (V3) gene, GENE, 241(1), 2000, pp. 57-64
Authors:
Tabarin, A
Achermann, JC
Recan, D
Bex, V
Bertagna, X
Christin-Maitre, S
Ito, M
Jameson, JL
Bouchard, P
Citation: A. Tabarin et al., A novel mutation in DAX1 causes delayed-onset adrenal insufficiency and incomplete hypogonadotropic hypogonadism, J CLIN INV, 105(3), 2000, pp. 321-328
Authors:
de Fraipont, F
El Atifi, M
Gicquel, C
Bertagna, X
Chambaz, EM
Feige, JJ
Citation: F. De Fraipont et al., Expression of the angiogenesis markers vascular endothelial growth factor-A, thrombospondin-1, and platelet-derived endothelial cell growth factor inhuman sporadic adrenocortical tumors: Correlation with genotypic alterations, J CLIN END, 85(12), 2000, pp. 4734-4741
Authors:
Barrande, G
Pittino-Lungo, M
Coste, J
Ponvert, D
Bertagna, X
Luton, JP
Bertherat, J
Citation: G. Barrande et al., Hormonal and metabolic effects of radiotherapy in acromegaly: Long-term results in 128 patients followed in a single center, J CLIN END, 85(10), 2000, pp. 3779-3785
Authors:
Bourcigaux, N
Gaston, V
Logie, A
Bertagna, X
Le Bouc, Y
Gicquel, C
Citation: N. Bourcigaux et al., High expression of cyclin E and G1 CDK and loss of function of p57(KIP2) are involved in proliferation of malignant sporadic adrenocortical tumors, J CLIN END, 85(1), 2000, pp. 322-330
Authors:
Groussin, L
Massias, JF
Bertagna, X
Bertherat, J
Citation: L. Groussin et al., Loss of expression of the ubiquitous transcription factor cAMP response element-binding protein (CREB) and compensatory overexpression of the activator CREM tau in the human adrenocortical cancer cell line H295R, J CLIN END, 85(1), 2000, pp. 345-354
Authors:
Ventura, MA
Rene, P
de Keyzer, Y
Bertagna, X
Clauser, E
Citation: Ma. Ventura et al., Gene and cDNA cloning and characterization of the mouse V3/V1b pituitary vasopressin receptor, J MOL ENDOC, 22(3), 1999, pp. 251-260
Citation: A. Picon et al., Analysis of the human proopiomelanocortin gene promoter in a small cell lung carcinoma cell line reveals an unusual role for E2F transcription factors, ONCOGENE, 18(16), 1999, pp. 2627-2633
Citation: A. Picon et al., Analysis of proopiomelanocortin gene transcription mechanisms in bronchialtumour cells, MOL C ENDOC, 147(1-2), 1999, pp. 93-102
Authors:
Raffin-Sanson, ML
Massias, JF
Ankotche, A
Coste, J
de Keyzer, Y
Oliver, C
Dumont, C
Cabrol, D
Ferre, F
Bertagna, X
Citation: Ml. Raffin-sanson et al., High precursor level in maternal blood results from the alternate mode of proopiomelanocortin processing in human placenta, CLIN ENDOCR, 50(1), 1999, pp. 85-94
Authors:
Arnaldi, G
de Keyzer, Y
Gasc, JM
Clauser, E
Bertagna, X
Citation: G. Arnaldi et al., Vasopressin receptors modulate the pharmacological phenotypes of Cushing'ssyndrome, ENDOCRINE R, 24(3-4), 1998, pp. 807-816
Authors:
Arnaldi, G
Mancini, V
Costantini, C
Giovagnetti, M
Petrelli, M
Masini, A
Bertagna, X
Mantero, F
Citation: G. Arnaldi et al., ACTH receptor mRNA in human adrenocortical tumors: Overexpression in aldosteronomas, ENDOCRINE R, 24(3-4), 1998, pp. 845-849
Authors:
Luton, JP
Bertherat, J
Kuhn, JM
Bertagna, X
Citation: Jp. Luton et al., Aberrant expression of GIP (Gastric Inhibitory Polypeptide) receptor in anadrenal cortical adenoma responsible for a case of food-dependent Cushing's syndrome, B ACA N MED, 182(9), 1998, pp. 1839-1850